James Reber Appointed VP of Global Sales
Hairmax® appoints James Reber as Vice President of Global Sales
27 oct. 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Hairmax®, the pioneer and global leader in transformation hair growth, has announced the promotion of James Reber as Vice President of Global...
nature wood logo.png
Nature Wood Group Limited Announces Partial Exercise of the Underwriter’s Over-Allotment Option
16 oct. 2023 15h16 HE | Nature Wood Group Limited
MACAU, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Nature Wood Group Limited (the “Company” or “Nature Wood”) (Nasdaq: NWGL), a global leading vertically-integrated forestry company that focuses on FSC...
July 30, 2021 - ROSEN LOGO.jpg
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – KVUE
15 oct. 2023 22h13 HE | The Rosen Law Firm PA
NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
Hairmax
Hairmax Partners with Breastcancer.org to support Breast Cancer Awareness Month
03 oct. 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in hair growth transformation, announced today that it will donate a percentage of sales during the month...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
29 sept. 2023 07h32 HE | Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
29 sept. 2023 07h30 HE | Structure Therapeutics Inc.
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...
Hennessy Capital Investment Corp. VI Announces Postponement of its Special Meeting of Stockholders to 3 P.M. ET on September 29
29 sept. 2023 01h07 HE | Hennessy Capital Investment Corp. VI
New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”)...
FirstLight_Logo.png
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
13 sept. 2023 05h50 HE | First Light Acquisition Group
Business combination transaction with First Light Acquisition Group, a special purpose acquisition company, completed on September 12, 2023 Gross proceeds made available to Calidi Biotherapeutics...
FirstLight_Logo.png
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments
11 sept. 2023 16h05 HE | First Light Acquisition Group
Business combination transaction with Calidi Biotherapeutics anticipated to be completed on September 12, 2023 Gross proceeds made available to Calidi Biotherapeutics from transaction will total...
hairmax-icon-black+V2.jpg
Hairmax® Appoints Francisco Cestero as Chief Financial Officer
07 sept. 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformation hair growth, announced today the appointment of Francisco Cestero, as Chief Financial...